SEC Form 4 · accession 0001062993-16-009883
BIOSPECIFICS TECHNOLOGIES CORP · BSTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Toby Wegman
Director
Period of report
May 18, 2016
Accepted (ET)
May 19, 2016 · 11:42 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875622
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par valueF1,F5 | May 18, 2016 | S | 50 | $33.80 | D | 1,005,128 | I | See footnote |
| Common Stock, $0.001 par valueF2,F5 | May 18, 2016 | S | 150 | $34.14 | D | 1,004,978 | I | See footnote |
| Common Stock, $0.001 par valueF3,F5 | May 18, 2016 | S | 50 | $34.11 | D | 1,004,928 | I | See footnote |
| Common Stock, $0.001 par valueF4,F5 | May 18, 2016 | S | 24,750 | $33.00 | D | 980,178 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The selling price of $33.80 is reflective of the sale price of all transactions reported on this line.
- F2The selling price of $34.14 is reflective of the sale price of all transactions reported on this line.
- F3The selling price of $34.11 is reflective of the sale price of all transactions reported on this line.
- F4The selling price of $33.00 is reflective of the sale price of all transactions reported on this line.
- F5These shares are held in trust on behalf of the reporting person and Mr. Thomas Wegman. The reporting person is the co-trustee of the trust with Mr. Thomas Wegman. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein.